(46 Total References)
BSACI Officers, Council & Executive
President: Dr Shuaib Nasser, Addenbrooke's Hospital, Cambridge
Clinical and Scientific Panel - Anaphylaxis campaign
Dr Shuaib Nasser
Dr Shuaib Nasser, Consultant in Allergy, Addenbrooke's, NHS Trust Hospital, Cambridge
Shuaib Nasser is Consultant in allergy and asthma at Cambridge University Hospitals NHS Foundation Trust - a regional Allergy centre.
trained in medicine, respiratory medicine and allergy in both London
clinical and research interests are in asthma, drug allergy and immunotherapy.
has published on aspirin-sensitive asthma, thunderstorm asthma, drug allergy, leukotrienes, asthma deaths and mechanisms of immunotherapy.
chairs the Standards of Care Committee of the British Society for Allergy and Clinical Immunology
which has led to the development of national guidelines on the management of urticaria, rhinitis, rhinosinusitis, drug allergy, anaphylaxis during general anaesthesia and egg allergy.
He was a member of the Resuscitation Council Working Group that published guidelines on the management of anaphylaxis.
He also sits on the Royal College of Physicians Clinical Effectiveness Forum and chairs the Eastern Region Confidential Enquiry into asthma deaths.
Dr Shuaib Nasser - BSACI ...
Dr Shuaib Nasser - BSACI President Elect
As a stalwart member of the BSACI, Dr Shuaib Nasser has been actively involved with the BSACI, and most notably established the Standard of Care Committee (SOCC), which he chaired between 2004-2012.
leadership SOCC published 8 national guidelines in Clinical & Experimental Allergy.
As further testament of the quality of guidelines produced BSACI guidelines have become accredited by the National Institute for Clinical Excellence
The open access guidelines are used in the UK & worldwide by allergy specialists.
continues to chair working parties & scientific meetings on drug allergy, and is a frequent contributor to allergy teaching locally and nationally.
Dr Nasser has been a consultant at Addenbrooke's Hospital, Cambridge for nearly 14 years, where he is recognised for clinical excellence and has made significant contributions to service development.
pioneered an asthma clinic where all Addenbrooke's
asthma admissions and patients with severe/difficult asthma from a large area are seen.
By looking for allergy triggers he
has improved outcomes.
work on a regional confidential enquiry into asthma deaths culminated in the publication of the RCP National Review of Asthma Deaths in May 2014.
developed the anti-IgE therapy service which requires skilled asthma management.
Increased referrals from regional respiratory physicians attest to his
Cambridge has one of the lowest hospital admission rates for asthma of any city in the UK.
broad knowledge and experience of drug allergy is revered in the UK.
further persuaded NICE
of the need for drug allergy guidance.
In 2012, he
was appointed by NICE
to chair the guideline on drug allergy and they were published in the BMJ in Sept 2014.
has developed protocols for investigation of all types of drug allergy and seen large numbers of patients at the Addenbrooke's
specialist drug allergy clinic over 19 years.
These examples provide a model for other tertiary centres.
has particular expertise in rhino-sinusitis, and set up a joint ENT/ allergy clinic for complex patients.
huge experience of immunotherapy is drawn on clinically, for research and in guidelines.
contributes to public understanding of allergy and his
influence on public policy is widespread.
He championed the need for allergy services through evidence based research, and was cited on national reviews including the House of Commons, Department of Health and House of Lords reports.
also made contributions to the RCP (Allergy the unmet need) and BSACI reports.
was consulted by NICE
as clinical expert on the technology appraisal for anti-IgE omalizumab in both asthma and urticaria.
made the government and the Chief Medical Officer (CMO) aware
of the need for an egg-free swine flu vaccine in egg allergic children and published on flu vaccination.
chaired the Eastern England confidential inquiry into asthma deaths, which was a pioneer in researching and identifying allergy as an important cause of asthma deaths.
As a result of identifying avoidable causes of death, he
persuaded the CMO to undertake a national asthma deaths inquiry.
also identified 'Alternaria' as a cause of acute asthma and thunderstorm asthma, leading to prevention strategies.
evidence influenced NICE
to amend criteria for omalizumab therapy, thus widening access.
Dr Shuaib Nasser's
aim is to continue making improvements to allergy care in the UK and BSACI
look forward to welcoming him as the new president after the BSACI 2015 Meeting.
Dr Shuaib Nasser - BSACI President Elect
As a stalwart member of the BSACI, Dr Shuaib Nasser has been actively involved with the BSACI, and most notably established the Standard of Care Committee (SOCC), which he chaired between..
Dr Shuaib Nasser, a ...
Dr Shuaib Nasser, a consultant allergist at Addenbrooke's Hospital in Cambridge, said there was a severe shortage of allergy specialists, and called for better training for doctors.
"What we need is education, starting from medical school upwards," he
told the inquiry.
Many patients, he
said, have "multi-system disorders" which are referred to separate specialists.
added: "The fault doesn't lie with the doctors themselves, it lies with the system."
Rentokil News | UKWaspWatch and The Anaphylaxis Campaign
Dr Shuaib Nasser, Consultant in Allergy, Addenbrooke's NHS Trust Hospital, Cambridge and member of The Anaphylaxis Campaign Clinical and Scientific Advisory Panel comments, "The prolonged warm weather has seen large numbers of wasps with many people reporting being stung.